InvestorsHub Logo
Followers 24
Posts 1115
Boards Moderated 0
Alias Born 06/15/2008

Re: Klinsmann post# 1119

Tuesday, 11/28/2017 8:46:32 AM

Tuesday, November 28, 2017 8:46:32 AM

Post# of 1990
We therefore believe that we now have sufficient funding to achieve this important milestone, as well as to continue to support the ongoing Phase 2 clinical trial of AGS-004 in combination with vorinostat targeting HIV eradication in adult patients.”
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.